In the choline-deficient L-amino acid-defined (CDAA) model of liver injury, although not associated with features of the metabolic syndrome, inflammasome activation occurred during steatohepatitis development, whereas Nlrp3−/− mice were protected during CDAA treatment22,23. The gene discussed is NLRP3; the disease is metabolic syndrome.